Oscar Health, Inc. (OSCR) Rises Higher Than Market: Key Facts
Oscar Health, Inc. (OSCR) closed at $11.73 in the latest trading session, marking a +2.27% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.72% for the day. Meanwhile, the Dow experienced a rise of 0.48%, and the technology-dominated Nasdaq saw an increase of 1.16%.
Prior to today's trading, shares of the company had lost 16.09% lagged the Finance sector's loss of 5.41% and the S&P 500's loss of 4.99%.
Investors will be eagerly watching for the performance of Oscar HealthOSCR--, Inc. in its upcoming earnings disclosure. In that report, analysts expect Oscar Health, Inc. to post earnings of $1.21 per share. This would mark year-over-year growth of 31.52%. Our most recent consensus estimate is calling for quarterly revenue of $4.89 billion, up 60.62% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $0.2 per share and a revenue of $18.91 billion, demonstrating changes of +111.83% and +61.62%, respectively, from the preceding year.
It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Digging into valuation, Oscar Health, Inc. currently has a Forward P/E ratio of 56.41. This indicates a premium in contrast to its industry's Forward P/E of 9.37.
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 152, placing it within the bottom 38% of over 250 industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Oscar Health, Inc. (OSCR): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners. Copyright 2006-2026 Zacks Equity Research, Inc. editor@zacks.com (Manaing editor) webmaster@zacks.com (Webmaster)
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet